$19.13
-3.81-16.61%
Last update: Nov 11, 7:44 AM
Hims & Hers Health Inc
HIMSNYSE
Hims & Hers Health fell 42.3% from $39.75 to $22.94, behind the S&P 500's +9.8%. Its worst day was Feb 9 (−16.0%), and its low came Feb 27 at $14.52.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Hims & Hers Health closed at its highest level of the year, 0.7% above where the year started.
+8.0% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Hims & Hers Health shares fell 16.0%, while the S&P 500 rose 0.5%.
−16.0%, the year's worst day · S&P 500 +0.5%
EPS of $0.08 beat the $0.03 estimate on $617.8M revenue (est. $618.0M); Q1 revenue guidance of $600.0M–$625.0M against the $650.1M consensus.
−0.3% · S&P 500 +0.7%
Needham moved Hims & Hers Health from Hold to Buy with a $30.00 price target; shares rose 40.8%.
+40.8%, the year's best day, on 175M shares, the year's heaviest volume · S&P 500 +0.9%
EPS of $-0.40 missed the $0.04 estimate on $608.1M revenue (est. $617.4M); Q2 revenue guidance of $680.0M–$700.0M against the $643.8M consensus.
−14.1% · S&P 500 −0.2%
Hims & Hers Health shares fell 14.7%, while the S&P 500 fell 1.5%.
−14.7% · S&P 500 −1.5%
EPS of $-0.37 missed the $-0.05 estimate on $753.2M revenue (est. $722.1M); Q3 revenue guidance of $880.0M–$900.0M against the $845.9M consensus.
−4.0% · S&P 500 −0.3%
Where it ended: a close of $22.94 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 22, 2027 (EPS est. $0.10, revenue est. $905.7M).
Nothing in the past 12 months.
All HIMS dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HIMS and SPY from Benzinga historical bars. Not investment advice.
